Roughly 86.4% of participants in the semaglutide arm lost at least 5% of body weight, and 69.1% lost at least 10%
The difference in results between local and non-local administration remains unclear from available research
(2024), DOI - 10.3390/nu16193262,
Alpha-kinase1 promotes tubular injury and interstitial inflammation in diabetic nephropathy by canonical pyroptosis pathway
In one study, older adults who got worn out after even light activity took 2 grams a day and came back with less physical fatigue, less mental fatigue, and better cognitive scores than the placebo group
This shift is supported by growing evidence that GLP-1s deliver multi-system benefits, from improved metabolic markers to reductions in cardiovascular risk, kidney disease progression, and other comorbidities common in people with type 2 diabetes or obesity